Cancer, IV Drips, and the Glutathione Vitamin C Connection

Is high-dose vitamin C good for you? High-dose intravenous vitamin C can selectively kill cancer cells in live patients and can save sepsis patients from dying, but it acts as a pro-oxidant in cancer and an antioxidant in sepsis. So what does it do in the rest of us? Oral doses of 2000 milligrams raise oxalate levels in most people, and as little as 400 milligrams raises oxalate in some people. This seems to be the most sensitive indicator of a delicate imbalance with glutathione and other factors needed to recycle vitamin C. Such a balance actually needs to be avoided when killing cancer yet is critical to maintaining health in every other context. Given that vitamin C is important to immunity and general health, how do we take advantage of these benefits without upsetting the delicate balance with glutathione and the propensity to generate oxalate? That is the topic of this podcast. This podcast is a preview of a video only available to Masterpass members. Get evergreen access to the video and podcast, as well as the written article with references, here: Chris Masterjohn, PhD, is the Founder and Scientific Director of the mitochondria test Mitome .

You can listen to Cancer, IV Drips, and the Glutathione Vitamin C Connection online on Radio and Podcast. Open the player on this page to stream the available audio.

Cancer, IV Drips, and the Glutathione Vitamin C Connection is an episode from Mastering Nutrition by Chris Masterjohn, PhD.

This episode is 02:10 long.

This episode was published on Nov 6, 2023.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Mastering Nutrition when more episodes are available from the podcast feed.